# reload+after+2024-01-21 20:43:17.257803
address1§825 Industrial Road
address2§Suite 500
city§San Carlos
state§CA
zip§94070
country§United States
phone§650 597 5002
website§https://www.allakos.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis; a Phase II/III study for eosinophilic esophagitis; and a Phase II clinical study to atopic dermatitis and chronic spontaneous urticaria. It is also developing lirentelimab (AK002) for the treatment of mast cell gastrointestinal disease, chronic urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis; and AK006 to treat allergic and inflammatory diseases. In addition, Allakos Inc. is conducting preclinical studies for AK007, which polarizes tumor-associated myeloid cells and promotes anti-tumor immunity. The company was incorporated in 2012 and is headquartered in San Carlos, California.
fullTimeEmployees§123
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Robert  Alexander Ph.D.', 'age': 53, 'title': 'CEO & Director', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 1458960, 'exercisedValue': 0, 'unexercisedValue': 9594228}, {'maxAge': 1, 'name': 'Dr. Adam L. Tomasi Ph.D.', 'age': 53, 'title': 'President', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 1114660, 'exercisedValue': 0, 'unexercisedValue': 4761198}, {'maxAge': 1, 'name': 'Mr. Baird  Radford III', 'age': 53, 'title': 'Chief Financial Officer', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 708260, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Mary  Cromwell Ph.D.', 'title': 'Chief Technical Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Craig  Paterson M.D.', 'age': 58, 'title': 'Chief Medical Officer', 'yearBorn': 1965, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Alan  Chang', 'title': 'Director of Medical Affairs & Data Analytics', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§7
boardRisk§7
compensationRisk§8
shareHolderRightsRisk§8
overallRisk§8
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.683
currency§USD
dateShortInterest§1702598400
forwardEps§-1.67
pegRatio§-0.05
exchange§NMS
quoteType§EQUITY
shortName§Allakos Inc.
longName§Allakos Inc.
firstTradeDateEpochUtc§1532007000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§42c6c158-c38d-3e00-b41e-7332226eb737
gmtOffSetMilliseconds§-18000000
targetHighPrice§22.0
targetLowPrice§1.5
targetMeanPrice§9.5
targetMedianPrice§8.0
recommendationMean§2.2
recommendationKey§buy
numberOfAnalystOpinions§5
quickRatio§8.269
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
